Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-27

Clinical Trial Update: Antimullerian Hormone Versus Antral Follicle Count for Determination of Gonadotrophin Dosing in IVF [NA]

View source ↗

Summary

A completed clinical trial comparing antimüllerian hormone versus antral follicle count for determining gonadotrophin dosing in IVF; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • antimüllerian hormone (anti-Müllerian hormone)

Snippet

Sponsor: The University of Hong Kong | Conditions: Infertility | NA | Status: COMPLETED | Results posted: 2019-02-27